Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism

Molecular and Cellular Endocrinology

Volumn 365, Issue 2, 2013, Pages 303-308

  Lim, Chung Thong ^a   Kola, Blerina ^a   Feltrin, Daniel ^a   Perez Tilve, Diego ^b   Tschöp, Matthias H ^b,c   Grossman, Ashley B ^a,d   Korbonits, Márta ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

AMPK; Cannabinoid receptor type 1; Cannabinoids; Ghrelin; Ghrelin receptor; Growth hormone secretagogue receptor knockout

Indexed keywords

CANNABINOID; DEXANABINOL; GHRELIN; GHRELIN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ENERGY; CELL METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME MECHANISM; HYPOTHALAMUS; INTRAABDOMINAL FAT; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; TISSUE SPECIFICITY;

ADENYLATE KINASE; ANIMALS; CANNABINOID RECEPTOR AGONISTS; ENERGY INTAKE; ENERGY METABOLISM; GENE EXPRESSION; GHRELIN; HYPOTHALAMUS; INTRA-ABDOMINAL FAT; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTOR, CANNABINOID, CB1; RECEPTORS, GHRELIN; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; TETRAHYDROCANNABINOL;

EID: 84871386255     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.11.007     Document Type: Article

References (39)

1. Andrews Z.B., Liu Z.W., Walllingford N., Erion D.M., Borok E., Friedman J.M., Tschop M.H., Shanabrough M., Cline G., Shulman G.I., Coppola A., Gao X.B., Horvath T.L., Diano S. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 2008, 454(7206):846-851.
2. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M.A., Kasuga M. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 2003, 52(7):947-952.
3. Avraham Y., Ben-Shushan D., Breuer A., Zolotarev O., Okon A., Fink N., Katz V., Berry E.M. Very low doses of delta 8-THC increase food consumption and alter neurotransmitter levels following weight loss. Pharmacol. Biochem. Behav. 2004, 77(4):675-684.
4. Baran K., Preston E., Wilks D., Cooney G.J., Kraegen E.W., Sainsbury A. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. Diabetes 2002, 51(1):152-158.
5. Cummings D.E. Ghrelin and the short- and long-term regulation of appetite and body weight. Physiol. Behav. 2006, 89(1):71-84.
6. Gao Q., Horvath T.L. Neurobiology of feeding and energy expenditure. Ann. Rev. Neurosci. 2007, 30:367-398.
7. Gnanapavan S., Kola B., Bustin S.A., Morris D.G., McGee P., Fairclough P., Bhattacharya S., Carpenter R., Grossman A.B., Korbonits M. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Clin. Endocrinol. Metab. 2002, 87(6):2988.
8. Graham Tobin K.A.S., Russell RobertJ Nutrition. The Mouse in Biomedical Research 2007, Elsevier, Oxford. J.G. Fox, S.W. Barthold, M.T. Davisson, C.E. Newcomer, F.W. Quimby, A.L. Smith (Eds.).
9. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Makela T.P., Alessi D.R., Hardie D.G. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003, 2(4):28.
10. Jamshidi N., Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br. J. Pharmacol. 2001, 134(6):1151-1154.
11. Jiang H., Betancourt L., Smith R.G. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol. Endocrinol. 2006, 20(8):1772-1785.
12. Kamegai J., Tamura H., Shimizu T., Ishii S., Sugihara H., Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001, 50(11):2438-2443.
13. Kirkham T.C., Tucci S.A. Endocannabinoids in appetite control and the treatment of obesity. CNS Neurol Disord Drug Targets 2006, 5(3):272-292.
14. Kirkham T.C., Williams C.M., Fezza F., Di Marzo V. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br. J. Pharmacol. 2002, 136(4):550-557.
15. Kirkham T.C. Endogenous cannabinoids: a new target in the treatment of obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284(2):R343-R344.
16. Kohno D., Gao H.Z., Muroya S., Kikuyama S., Yada T. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 2003, 52(4):948-956.
17. Kojima M., Hosoda H., Kangawa K. Clinical endocrinology and metabolism. Ghrelin, a novel growth-hormone-releasing and appetite-stimulating peptide from stomach. Best Pract. Res. Clin. Endocrinol. Metab. 2004, 18(4):517-530.
18. Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., Williams L.M., Hawley S.A., Hardie D.G., Grossman A.B., Korbonits M. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J. Biol. Chem. 2005, 280(26):25196-25201.
19. Kola B., Boscaro M., Rutter G.A., Grossman A.B., Korbonits M. Expanding role of AMPK in endocrinology. Trends Endocrinol. Metab. 2006, 17(5):205-215.
20. Kola B., Farkas I., Christ-Crain M., Wittmann G., Lolli F., Amin F., Harvey-White J., Liposits Z., Kunos G., Grossman A.B., Fekete C., Korbonits M. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 2008, 3(3):e1797.
21. Korbonits M., Goldstone A.P., Gueorguiev M., Grossman A.B. Ghrelin - a hormone with multiple functions. Front Neuroendocrinol. 2004, 25(1):27-68.
22. Lim C.T., Kola B., Korbonits M. AMPK as a mediator of hormonal signalling. J. Mol. Endocrinol. 2010, 44(2):87-97.
23. Mano-Otagiri A., Nemoto T., Sekino A., Yamauchi N., Shuto Y., Sugihara H., Oikawa S., Shibasaki T. Growth hormone-releasing hormone (GHRH) neurons in the arcuate nucleus (Arc) of the hypothalamus are decreased in transgenic rats whose expression of ghrelin receptor is attenuated: Evidence that ghrelin receptor is involved in the up-regulation of GHRH expression in the arc. Endocrinology 2006, 147(9):4093-4103.
24. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferre P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428(6982):569-574.
25. Olszewski P.K., Grace M.K., Billington C.J., Levine A.S. Hypothalamic paraventricular injections of ghrelin: effect on feeding and c-Fos immunoreactivity. Peptides 2003, 24(6):919-923.
26. Osei-Hyiaman D., DePetrillo M., Pacher P., Liu J., Radaeva S., Batkai S., Harvey-White J., Mackie K., Offertaler L., Wang L., Kunos G. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 2005, 115(5):1298-1305.
27. Rigault C., Le Borgne F., Georges B., Demarquoy J. Ghrelin reduces hepatic mitochondrial fatty acid beta oxidation. J. Endocrinol. Invest. 2007, 30(4):RC4-RC8.
28. Sangiao-Alvarellos S., Vazquez M.J., Varela L., Nogueiras R., Saha A.K., Cordido F., Lopez M., Dieguez C. Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion. Endocrinology 2009, 150(10):4562-4574.
29. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA M 2004, 101(13):4679-4684.
30. Tschop M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407(6806):908-913.
31. Tucci S.A., Rogers E.K., Korbonits M., Kirkham T.C. The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. Br. J. Pharmacol. 2004, 143(5):520-523.
32. Turu G., Simon A., Gyombolai P., Szidonya L., Bagdy G., Lenkei Z., Hunyady L. The role of diacylglycerol lipase in constitutive and angiotensin AT1 receptor-stimulated cannabinoid CB1 receptor activity. J. Biol. Chem. 2007, 282(11):7753-7757.
33. Wiley J.L., Burston J.J., Leggett D.C., Alekseeva O.O., Razdan R.K., Mahadevan A., Martin B.R. CB1cannabinoid receptor-mediated modulation of food intake in mice. Br. J. Pharmacol. 2005, 145(3):293-300.
34. Williams C.M., Rogers P.J., Kirkham T.C. Hyperphagia in pre-fed rats following oral delta9-THC. Physiol. Behav. 1998, 65(2):343-346.
35. Williams C.M., Kirkham T.C. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology (Berlin) 1999, 143(3):315-317.
36. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 2001, 86(12):5992.
37. Wren A.M., Small C.J., Abbott.C.R., Dhillo W.S., Seal L.J., Cohen M.A., Batterham R.L., Taheri S., Stanley S.A., Ghatei M.A., Bloom S.R. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001, 50(11):2540-2542547.
38. Xue B., Kahn B.B. AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J. Physiol. 2006, 574(Pt. 1):73-83.
39. Zhao T.J., Liang G., Li R.L., Xie X., Sleeman M.W., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Goldstein J.L., Brown M.S. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc. Natl. Acad. Sci. USA 2010, 107(16):7467-7472.